Skip to main content

Table 2 Factors related to presence of cervical lesions

From: Co-infection of sexually transmitted pathogens and Human Papillomavirus in cervical samples of women of Brazil

Variables Without cervix lesions With cervix lesions OR (Crude) OR (Adjusted)b
n = 70 (%) n = 62 (%) P (Wald’s test) OR IC 95% P (Wald’s test) OR IC 95%
  n (%) n (%)       
Demographic and sexual profile
 Age
  ≤ 31 years 28 (40.0) 16 (25.8) 0.161 1    1  
  32–42 years 19 (27.1) 25 (40.3) 0.057 2.30 0.98–5.42 0.316 2.27 0.46–11.18
  43 years or more 23 (32.9) 21 (33.9) 0.281 1.60 0.68–3.75 0.470 0.57 0.12–2.64
 Residence
  Urban area 60 (85.7) 41 (66.1)   1     
  Countryside 10 (14.3) 21 (33.9) 0.010 3.07 1.31–7.20    
 Education level
  At least primary school completed 39 (55.7) 18 (29.0)   1     
  Less than primary school 31 (44.3) 44 (71.0) 0.002 3.08 1.49–6.34    
 In a stable relationship
  No 57 (81.4) 16 (25.8)   1    1  
  Yes 13 (18.6) 46 (74.2) <0.0001 12.01 5.51–28.87 < 0.001 14.21 3.67–55.02
 N° of sexual partners in all life
  1 30 (42.9) 16 (25.8) 0.121 1     
  2–5 34 (48.6) 38 (61.3) 0.057 2.10 0.98–4.50    
  > 5 6 (8.6) 8 (12.9) 0.141 2.50 0.738–8.47    
 Ethnic group declared
  White 17 (24.3) 13 (21.0)   1     
  No white 53 (75.7) 49 (79.0) 0.650 1.21 0.53–2.75    
 Condom use
  Always 12 (17.6)a 11 (17.7) 0.988 1     
  Sometimes 15 (22.1)a 13 (21.0) 0.921 0.92 0.31–2.85    
  Never/rarely 41 (60.3)a 38 (61.3) 0.981 1.01 0.40–2.56    
 Contraceptive pills/hormone injection use
  No 44 (62.9) 43 (69.4)   1     
  Yes 26 (37.1) 19 (30.6) 0.432 0.75 0.36–1.55    
 Pregnancy
  0 6 (8.6) 3 (4.8) 0.425 1     
  1–2 34 (48.6) 26 (41.9) 0.573 1.53 0.35–6.70    
  ≥ 3 30 (42.9) 33 (53.2) 0.294 2.20 0.51–9.58    
 Abortion
  No 42 (60.0) 43 (69.4)   1     
  Yes 28 (40.0) 19 (30.6) 0.264 0.66 0.32–1.36    
STA detection
 HPV
  Negative 52 (74.3) 9 (14.5)   1   < 0.001 1  
  Positive 18 (25.7) 53 (85.5) <0.001 17.01 7.01–41.23 16.81 4.19–67.42
Mollicutes
  Negative 22 (31.4) 5 (8.1)   1     
  Positive 48 (68.6) 57 (91.9) 0.002 5.23 1.84–14.85  
U. parvum (qPCR)
  Negative 29 (41.4) 13 (21.0)   1    1 0.36–5.98
  Positive 41 (58.6) 49 (79.0) 0.013 2.66 1.23–5.79 0.593 1.47  
U. parvum (PCR)
  Negative 35 (50.0) 30 (48.4)   1     
  Positive 35 (50.0) 32 (51.6) 0.853 1.07 0.54–2.11    
U. parvum serotype 1
  Negative 61 (87.1) 61 (98.4)   1     
  Positive 9 (12.9) 1 (1.6) 0.040 0.11 0.01–0.90    
U. parvum serotypes 3/14
  Negative 60 (85.7) 51 (82.3)   1     
  Positive 10 (14.3) 11 (17.7) 0.589 1.29 0.51–3.29    
U. parvum serotype 6
  Negative 53 (75.7) 61 (98.4)   1     
  Positive 17 (24.3) 1 (1.6) 0.004 0.05 0.007–0.40    
U. urealyticum (qPCR)
  Negative 61 (87.1) 54 (87.1)   1     
  Positive 9 (12.9) 8 (12.9) 0.994 1.00 0.36–2.79    
U. urealyticum (PCR)
  Negative 67 (95.7) 57 (91.9)   1     
  Positive 3 (4.3) 5 (8.1) 0.371 1.96 0.45–8.56    
T. vaginalis
  Negative 66 (94.3) 24 (38.7)   1   0.003 1 2.04–35.94
  Positive 4 (5.7) 38 (61.3) <0.001 26.13 8.43–80.98   8.566  
G. vaginalis
  Negative 33 (47.1) 5 (8.1)   1   0.011 1 1.53–24.61
  Positive 37 (52.9) 57 (91.9) <0.001 10.17 3.64–28.41   6.13  
C. trachomatis
  Negative 69 (98.6) 60 (96.8)   1     
  Positive 1 (1.4) 2 (3.2) 0.501 2.30 0.20–26.00    
N. gonorrhoeae
  Negative 55 (78.6) 62 (100.0)   1     
  Positive 15 (21.4) 0 (0) 0.998 0     
  1. atwo women did not declare using condoms
  2. badjusted for age and positivity in qPCR for U. parvum. The goodness of the adjustment was evaluated by Hosmer-Lemershow test (p = 0.568)